Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0EX1C
|
||||
| Former ID |
DIB002066
|
||||
| Drug Name |
RASV-Sp
|
||||
| Synonyms |
Recombinant attenuated Salmonella Typhi vaccine vectors expressing the Streptococcus pneumoniae surface protein (PspA) alpha-helical domain fused to B-lactamase (oral, Streptococcus pneumoniae infection), Arizona State University
|
||||
| Drug Type |
Vaccine
|
||||
| Indication | Streptococcus pneumoniae infection [ICD10:J13] | Phase 1 | [1] | ||
| Company |
Arizona State University
|
||||
| Target and Pathway | |||||
| Target(s) | Beta-lactamase | Target Info | [2] | ||
| References | |||||
| REF 1 | Rapid, Sensitive Recovery of Recombinant Attenuated Salmonella enterica Serovar Typhi Vaccine Strains from Human Blood. Clin Vaccine Immunol. 2013 September; 20(9): 1473-1478. | ||||
| REF 2 | WO patent application no. 2010,0456,20, Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.